{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:35:54Z","timestamp":1793367354439,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2022206443"],"award-info":[{"award-number":["H2022206443"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejso.2026.112025","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:36:37Z","timestamp":1784936197000},"page":"112025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic analysis of patients with esophageal squamous cell carcinoma based on tumor differentiation in the setting of neoadjuvant chemotherapy combined with immunotherapy: A single-center retrospective study"],"prefix":"10.1016","volume":"52","author":[{"given":"Weilu","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyv","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2574-7891","authenticated-orcid":false,"given":"Huilai","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.ejso.2026.112025_bib1","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1097\/CM9.0000000000003442","article-title":"Comparative analysis of cancer statistics in China and the United States in 2024","volume":"137","author":"Wu","year":"2024","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.ejso.2026.112025_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ejso.2026.112025_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ijc.33976","article-title":"Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): a multicenter, phase 2 study","volume":"151","author":"Liu","year":"2022","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2026.112025_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10388-024-01054-y","article-title":"Japanese classification of esophageal cancer,th 12 edition","volume":"21","author":"Mine","year":"2024","journal-title":"partI Esophagus"},{"issue":"3","key":"10.1016\/j.ejso.2026.112025_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10388-024-01054-y","article-title":"Japanese classification of esophageal cancer,12thedition: parti","volume":"21","author":"Mine","year":"2024","journal-title":"Esophagus"},{"key":"10.1016\/j.ejso.2026.112025_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fonc.2024.1442212","article-title":"Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis","volume":"14","author":"Deng","year":"2024","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2026.112025_bib9","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.ccell.2024.09.008","article-title":"A prospective study of neoadjuvant pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma: the Keystone-001 trial","volume":"42","author":"Shang","year":"2024","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.ejso.2026.112025_bib10","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1038\/s41591-024-03064-w","article-title":"Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO\/NCCES01 trial","volume":"30","author":"Qin","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2026.112025_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-1-0716-0377-2_2","article-title":"Histopathological assessment for esophageal squamous cell carcinoma","volume":"2129","author":"Lam","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ejso.2026.112025_bib12","first-page":"250","article-title":"Clinical efficacy of anlotinib plus s-1 as a second-line therapy for recurrent or metastatic esophageal squamous cell carcinoma","volume":"41","author":"Sun","year":"2021","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao = J Southern Med Univ"},{"key":"10.1016\/j.ejso.2026.112025_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40364-024-00656-z","article-title":"Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma","volume":"12","author":"Jiang","year":"2024","journal-title":"Biomarker Res"},{"key":"10.1016\/j.ejso.2026.112025_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216951","article-title":"The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma","volume":"593","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejso.2026.112025_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/biom14050519","article-title":"Modeling radiation-induced epithelial cell injury in murine three-dimensional esophageal organoids","volume":"14","author":"Carswell","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejso.2026.112025_bib16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1186\/s12885-025-13938-y","article-title":"Clinicopathological characteristics and the relationship of PD-L1 status, tumor mutation burden, and microsatellite instability in patients with esophageal carcinoma","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2026.112025_bib17","article-title":"Mechanisms of esophageal cancer metastasis and treatment progress","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ejso.2026.112025_bib18","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1245\/s10434-023-13655-5","article-title":"Mapping of lymph node metastasis and efficacy index in thoracic esophageal squamous cell carcinoma: a large-scale retrospective analysis","volume":"30","author":"Li","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112025_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41392-025-02306-8","article-title":"Comprehensive genomic and transcriptomic analyses reveal prognostic stratification for esophageal squamous cell carcinoma","volume":"10","author":"Gao","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejso.2026.112025_bib20","doi-asserted-by":"crossref","unstructured":"Hui Wang, Feiyan Deng, Qian Liu, et al. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma, Pathol Res Pract,Volume 213, Issue 7201, Pages 842-847, ISSN 0344-0338.","DOI":"10.1016\/j.prp.2017.01.023"},{"issue":"10","key":"10.1016\/j.ejso.2026.112025_bib21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/00365521.2025.2548604","article-title":"Prognostic difference of esophageal squamous cell carcinoma based on tumor differentiation: a single center retrospective study","volume":"60","author":"Hayashi","year":"2025","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ejso.2026.112025_bib22","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jtcvs.2023.09.055","article-title":"Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma","volume":"167","author":"McKay","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejso.2026.112025_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12885-023-10687-8","article-title":"Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2026.112025_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12893-025-03016-2","article-title":"Does pathological complete response after neoadjuvant chemoradiotherapy associate with long-term survival in esophageal cancer: a systematic review and meta-analysis","volume":"25","author":"Sun","year":"2025","journal-title":"BMC Surg"},{"key":"10.1016\/j.ejso.2026.112025_bib25","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1245\/s10434-020-09219-6","article-title":"Pretreatment primary tumor stage is a risk factor for recurrence in patients with esophageal squamous cell carcinoma who achieve pathological complete response after neoadjuvant chemoradiotherapy","volume":"28","author":"Mendola","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112025_bib26","article-title":"Liquid biopsies and minimal residual disease in lymphoid malignaNCITes","volume":"13","author":"Zerdan","year":"2023","journal-title":"Front Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832600644X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832600644X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:46:55Z","timestamp":1793364415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879832600644X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S074879832600644X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112025","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic analysis of patients with esophageal squamous cell carcinoma based on tumor differentiation in the setting of neoadjuvant chemotherapy combined with immunotherapy: A single-center retrospective study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112025"}}